Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial

BACKGROUND: Patients hospitalised with COVID-19 are at risk for thrombotic events after discharge; the role of extended thromboprophylaxis in this population is unknown. METHODS: In this open-label, multicentre, randomised trial conducted at 14 centres in Brazil, patients hospitalised with COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramacciotti, Eduardo, Barile Agati, Leandro, Calderaro, Daniela, Aguiar, Valéria Cristina Resende, Spyropoulos, Alex C, de Oliveira, Caroline Candida Carvalho, Lins dos Santos, Jessica, Volpiani, Giuliano Giova, Sobreira, Marcone Lima, Joviliano, Edwaldo Edner, Bohatch Júnior, Milton Sérgio, da Fonseca, Benedito Antônio Lopes, Ribeiro, Maurício Serra, Dusilek, Cesar, Itinose, Kengi, Sanches, Suzanna Maria Viana, de Almeida Araujo Ramos, Karine, de Moraes, Nara Franzin, Tierno, Paulo Fernando Guimarães Morando Marzocchi, de Oliveira, André Luiz Malavasi Longo, Tachibana, Adriano, Chate, Rodrigo Caruso, Santos, Marcus Vinícius Barbosa, de Menezes Cavalcante, Bruno Bezerra, Moreira, Ricardo Cesar Rocha, Chang, Chiann, Tafur, Alfonso, Fareed, Jawed, Lopes, Renato D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673881/
https://www.ncbi.nlm.nih.gov/pubmed/34921756
http://dx.doi.org/10.1016/S0140-6736(21)02392-8

Ejemplares similares

Ejemplares similares